期刊文献+

国产长春瑞滨联合顺铂治疗转移性乳腺癌的临床观察 被引量:5

Combination Chemotherapy With Vinorelbine and Cisplatin in the Treatment of Metastatic Breast Cancer
暂未订购
导出
摘要 目的 :观察国产长春瑞滨 (盖诺 )联合顺铂方案治疗转移性乳腺癌的临床疗效。方法 :运用盖诺 (2 5mg/m2 IVDd1,d8)加顺铂 (DDP 80mg/m2 IVd1)治疗转移性乳腺癌 2 6例。结果 :取得CR 3例 (11 5 %) ,PR 12例 (46 1%) ,总有效率RR(CR+PR)达 5 7 6 %。主要毒副作用为骨髓抑制 ,胃肠道反应和静脉炎。白细胞减少的发生率 10 0 %,其中Ⅲ~Ⅳ度达 5 7 7%。恶心、呕吐的发生率 92 3%,Ⅲ~Ⅳ度达 11 5 %。静脉炎的发生率 15 4 %。结论 :国产长春瑞滨联合顺铂对转移性乳腺癌疗效确切 ,且毒性可以耐受 ,可以作为对蒽环类药物治疗后复发 ,转移乳腺癌患者的二线治疗方案。 Objective:To evaluate the effective of combination chemotheraphy of NVB plus cisplatin on metastatic breast cancer.Methods:26 patients of metastatic breast cancer were treated with NVB 25mg/m 2 IVD for day1 and day8 and cisplatin 80mg/m 2 IV for day1.Results:Complete response was observed in 3 patients,partial response in 12 patients,with an overall response rate of 57.6%,The most common toxicities were seen myelosuppression,vomiting and phlebitis.Leukopenia was observed in all patients(100%) and grade 3 and grade 4 leukopenia in most of patients(57.7%).The rates of vomiting were 92.3%,and grade 3 and grade 4 vomiting were 11.5%.The rates of phlebitis were 15.4%.Conclusion:The NP combination chemotheraphy was effective for metastatic breast cancer and the toxicities were tolerable,It serves as the second line chemotherapy regimen on patient with anthracycline-resistant metastatic breast cancer.
作者 王燕
出处 《临床肿瘤学杂志》 CAS 2003年第4期298-298,F003,共2页 Chinese Clinical Oncology
关键词 春瑞滨 顺铂 联合治疗 转移性乳腺癌 临床观察 疗效 毒副作用 Vinorelabine Cisplatin Combination chemotherapy Metastatic breast cancer
  • 相关文献

参考文献6

二级参考文献10

  • 1张载福 王迪浔.炎症介质.病理生理学(第1版)[M].北京:人民卫生出版社,1996.109-12.
  • 2杨永年 朱宝荣.肾上腺皮质激素在内科疾病中的应用.上海医科大学实用内科学[M].北京:人民卫生出版社,1994.2376-2376.
  • 3王晓红,浙江肿瘤,1999年,13期,54页
  • 4张载福,病理生理学,1996年,109页
  • 5杨永年,上海医科大学实用内科学,1994年,2页
  • 6Antoine Adenis,Jean-Marc Pion,Pierre Fumoleau,Pierre Pouillart,Michel Marty,Bruno Giroux,Jacques Bonneterre. Phase II study of a new vinca alkaloid derivative, S12363, in advanced breast cancer[J] 1995,Cancer Chemotherapy and Pharmacology(6):527~528
  • 7孙燕,周际昌.临床肿瘤内科手册[M]人民卫生出版社,1996.
  • 8王晓红,马建群,姜景山,刘希安.去甲长春花碱加Vp16治疗恶性淋巴瘤临床评价[J].实用肿瘤学杂志,1999,13(1):53-54. 被引量:8
  • 9管忠震,赵体平,孙燕,姜文奇,洪小兰.异环磷酰胺治疗恶性淋巴瘤及小细胞型肺癌的Ⅱ期临床观察[J].癌症,1992,11(3):174-176. 被引量:23
  • 10张湘茹,孙燕.新抗肿瘤药异长春花碱[J].北京医学,1992,14(3):171-176. 被引量:147

共引文献322

同被引文献30

  • 1潘启超.长春碱类的新进展──失碳长春碱[J].癌症,1996,15(3):228-231. 被引量:276
  • 2Roasi A, Gridelli C, Gebbia V, et al. Single agent vinorelbine as first line chemotherapy in elderly patients with advanced breast cancer [J]. Anlicaneer Res, 2006 Mar-Apt, 23 (2C) : 1657-1664.
  • 3Deeatris MP, Sundar S, O' Byme KJ. Platinum-based chemotherapy in metastatic breast cancer:current status [J]. Cancer Treat Rev, 2007 ,Feb, 30(1) :53-81.
  • 4胡月棣 李春波.预防诺维本致静脉炎的临床分析.中国肿瘤临床,2006,:531-532.
  • 5王吉耀 廖二元 胡品津.内科学[M]:第7版[M].北京:人民卫生出版社,2003.434-435.
  • 6周际昌.实用肿瘤内科学[M](第2版)[M].北京:人民卫生出版社,2002.45-48.
  • 7周际昌.实用肿瘤内科学[M].北京:人民卫生出版社,2005:601~610.
  • 8Ray-Coquard I, Bion P, Bachelot T, et al. Vinorelbine and cisplatin for the treatment of metastatic breast carcinoma after failure of anthracycline and/or paclitaxel-contaning regimens [J]. Cancer,1998,82(1):134-140.
  • 9Bonadonna G. Vinorelbine:an active non cross resistant drug in advanced breast cancer, Results from a phase Ⅱ stud[J]. Bresat Cancer Research and Treatment, 199G, 39 : 285-291.
  • 10Martin M. Platinym compounds in the theatment of advanced breast cancer[J]. Clin Breast Cancer, 2001,2(3): 190.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部